United States · 
What does Accelmed invest in?
Accelmed invests most often at Series D and Venture (100% of the rounds on record), in sectors such as Medical Devices, Tools & Diagnostics and Digital Health.
Accelmed highlights
- 01
6 rounds on record
- 02
Mostly Series D and Venture: 100% of its rounds
- 03
Sole investor in 2 rounds, median $25M
What they do
We take a private equity approach to a sector that’s traditionally been dominated by venture and early-stage growth firms.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Medical DevicesTools & DiagnosticsDigital Health
- Based in
- Miami, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2019
2 rounds
- May
- Jan
- 2015
1 round
- Mar
- 2014
1 round
- Jul
- 2013
1 round
- Jan
- 2011
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
UGUri GeigerExecutive OfficeriFiling they signed
We also hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$401Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Accelmed Partners II Management, LLC
- SEC number
- CRD 308981
What they claim to have backed
From their own portfolio page (on their website)
11 of 27 we have independently watched raise
AicureClicktherapeuticsCorviamedicalGtmedtechKeystonedentalMedminderMedminderNeuropaceSonivieTailormedValcaremedicalAcclaromdBionessrehabCynerioDigmamedicalHome - Axora MedicalMemicmedMomentissurgicalNitinotesurgicalRevampmedicalSeaspineSknvStrataskinsciencesThe Actionability PlatformVarianVeranexsolutionsZimmerbiomet
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.